U.S. Department of the Treasury

Asia
Pharma

COINS Act, Hengrui, Samsung Biologics—Fierce Pharma Asia

The Treasury Department closed in on U.S. investments in China life-sci. Hengrui discussed its secret sauce. Samsung Bio averted a strike, for now.
Fraiser Kansteiner Oct 23, 2026 8:42am
Graphic of a puzzle depicting both the US and Chinese flags with missing pieces bridging the two together
Favicon Fierce Biotech

Treasury COINS rules add biotech, spares China licensing deals

Oct 22, 2026 11:36pm
Asia

US' China deal policy, WCLC, Legend CEO—Fierce Pharma Asia

Sep 18, 2026 10:20am
Congress senate house government US

Bipartisan bill targets foreign drugmaking in US

Jul 16, 2026 11:27am
graphic image of China flags overlapping with US flags
Favicon Fierce Biotech

Will COINS Act kill China biotech licensing boom?

May 26, 2026 3:50pm
court decision

AbbVie dodges hedge fund lawsuit over failed $55B Shire pursuit

Sep 14, 2021 4:00pm